Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diseases of the Thyroid

  Free Subscription


Articles published in Endocr J

Retrieve available abstracts of 85 articles:
HTML format
Text format



Single Articles


    October 2017
  1. HE L, Shen C, Zhang Y, Chen Z, et al
    Evaluation of serum ferritin and thyroid function in the second trimester of pregnancy.
    Endocr J. 2017 Oct 13. doi: 10.1507/endocrj.EJ17-0253.
    PubMed     Text format     Abstract available


    September 2017
  2. HIROKAWA M, Higuchi M, Suzuki A, Hayashi T, et al
    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan.
    Endocr J. 2017 Sep 12. doi: 10.1507/endocrj.EJ17-0214.
    PubMed     Text format     Abstract available


  3. SATOH M, Aso K, Nakayama T, Saji T, et al
    Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension.
    Endocr J. 2017 Sep 9. doi: 10.1507/endocrj.EJ17-0155.
    PubMed     Text format     Abstract available


  4. SUZUKI A, Hirokawa M, Takada N, Higuchi M, et al
    Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Endocr J. 2017 Sep 5. doi: 10.1507/endocrj.EJ17-0238.
    PubMed     Text format     Abstract available


  5. AOYAMA M, Takizawa H, Tsuboi M, Nakagawa Y, et al
    A case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy.
    Endocr J. 2017 Sep 5. doi: 10.1507/endocrj.EJ17-0220.
    PubMed     Text format     Abstract available


  6. NARUMI S, Fox LA, Fukudome K, Sakaguchi Z, et al
    Mild thyroid peroxidase deficiency caused by TPO mutations with residual activity: Correlation between clinical phenotypes and enzymatic activity.
    Endocr J. 2017 Sep 1. doi: 10.1507/endocrj.EJ17-0194.
    PubMed     Text format     Abstract available


    August 2017
  7. SAWA A, Chiba T, Ishii J, Yamamoto H, et al
    Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells.
    Endocr J. 2017 Aug 31. doi: 10.1507/endocrj.EJ16-0525.
    PubMed     Text format     Abstract available


  8. WU W, Gong X, Zhou Q, Chen X, et al
    US-guided percutaneous microwave ablation for the treatment of benign thyroid nodules.
    Endocr J. 2017 Aug 29. doi: 10.1507/endocrj.EJ17-0152.
    PubMed     Text format     Abstract available


  9. TOMARI S, Watanabe M, Inoue N, Mizuma T, et al
    The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of TPOAb.
    Endocr J. 2017 Aug 25. doi: 10.1507/endocrj.EJ17-0191.
    PubMed     Text format     Abstract available


  10. TAKADA N, Hirokawa M, Ito M, Ito A, et al
    Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases.
    Endocr J. 2017 Aug 10. doi: 10.1507/endocrj.EJ17-0242.
    PubMed     Text format     Abstract available


  11. BOGDANOVA TI, Saenko VA, Hirokawa M, Ito M, et al
    Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
    Endocr J. 2017 Aug 10. doi: 10.1507/endocrj.EJ17-0134.
    PubMed     Text format     Abstract available


  12. NISHIHARA E, Amino N, Kudo T, Ito M, et al
    Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases.
    Endocr J. 2017 Aug 2. doi: 10.1507/endocrj.EJ17-0164.
    PubMed     Text format     Abstract available


    July 2017
  13. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Preoperative diagnostic algorithm of primary thyroid lymphoma using ultrasound, aspiration cytology, and flow cytometry.
    Endocr J. 2017 Jul 8. doi: 10.1507/endocrj.EJ17-0111.
    PubMed     Text format     Abstract available


  14. HIROKAWA M, Miyauchi A, Kihara M, Kudo T, et al
    Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex.
    Endocr J. 2017 Jul 6. doi: 10.1507/endocrj.EJ17-0096.
    PubMed     Text format     Abstract available


    June 2017
  15. MASAKI C, Sugino K, Saito N, Saito Y, et al
    Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
    Endocr J. 2017 Jun 28. doi: 10.1507/endocrj.EJ17-0104.
    PubMed     Text format     Abstract available


  16. SUGISAWA C, Higuchi S, Takagi M, Hasegawa Y, et al
    Homozygous DUOXA2 mutation (p.Tyr138*) in a girl with congenital hypothyroidism and her apparently unaffected brother: Case report and review of the literature.
    Endocr J. 2017 Jun 16. doi: 10.1507/endocrj.EJ16-0564.
    PubMed     Text format     Abstract available


  17. TAKADA N, Hirokawa M, Suzuki A, Higuchi M, et al
    Reappraisal of "cyst fluid only" on thyroid fine-needle aspiration cytology.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ17-0082.
    PubMed     Text format     Abstract available


  18. XIN W, Yu Y, Ma Y, Gao Y, et al
    Thyroid-stimulating hormone stimulation downregulates autophagy and promotes apoptosis in chondrocytes.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ16-0534.
    PubMed     Text format     Abstract available


    May 2017
  19. INOUE N, Watanabe M, Nakaguchi A, Ueda D, et al
    Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases.
    Endocr J. 2017 May 16. doi: 10.1507/endocrj.EJ16-0551.
    PubMed     Text format     Abstract available


    April 2017
  20. HIGUCHI S, Takagi M, Hasegawa Y
    Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas.
    Endocr J. 2017 Apr 18. doi: 10.1507/endocrj.EJ16-0559.
    PubMed     Text format     Abstract available


  21. KE W, Sun T, Zhang Y, He L, et al
    25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Endocr J. 2017 Apr 11. doi: 10.1507/endocrj.EJ16-0547.
    PubMed     Text format     Abstract available


    March 2017
  22. LI X, Zhen D, Zhao M, Liu L, et al
    Natural history of mild subclinical hypothyroidism in a middle-aged and elderly Chinese population: a prospective study.
    Endocr J. 2017 Mar 7. doi: 10.1507/endocrj.EJ16-0549.
    PubMed     Text format     Abstract available


  23. YALCIN MM, Altinova AE, Cavnar B, Bolayir B, et al
    Is thyroid autoimmunity itself associated with psychological well-being in euthyroid Hashimoto's thyroiditis?
    Endocr J. 2017 Mar 4. doi: 10.1507/endocrj.EJ16-0418.
    PubMed     Text format     Abstract available


    February 2017
  24. AKEHI Y, Hashimoto Y, Meren J, Tanabe M, et al
    Postpartum hypothalamic adrenal insufficiency with remission: A rare case.
    Endocr J. 2017;64:157-162.
    PubMed     Text format     Abstract available


  25. TAKANO T
    Natural history of thyroid cancer [Review].
    Endocr J. 2017 Feb 2. doi: 10.1507/endocrj.EJ17-0026.
    PubMed     Text format     Abstract available


    December 2016
  26. KIM JW, Woo YJ, Yoon JS
    Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?
    Endocr J. 2016;63:1133-1140.
    PubMed     Text format     Abstract available


  27. NOMURA R, Miyai K, Kuge R, Okura T, et al
    Free T3 to free T4 ratio less than 2.0 suggests low T3 syndrome rather than central hypothyroidism from the age of two to eighteen years.
    Endocr J. 2016 Dec 22. doi: 10.1507/endocrj.EJ16-0169.
    PubMed     Text format     Abstract available


    November 2016
  28. KOBAYASHI S, Yoshimura Noh J, Shimizu T, Sato T, et al
    A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH).
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  29. ITO Y, Hirokawa M, Miyauchi A, Kihara M, et al
    Diagnosis and surgical indications of oxyphilic follicular tumors in Japan: Surgical specimens and cytology.
    Endocr J. 2016;63:977-982.
    PubMed     Text format     Abstract available


  30. HE Y, Mu K, Liu R, Zhang J, et al
    Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    October 2016
  31. SATOH T, Isozaki O, Suzuki A, Wakino S, et al
    2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    September 2016
  32. ODA H, Miyauchi A, Ito Y, Sasai H, et al
    Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  33. YOSHIHARA A, Yoshimura Noh J, Mukasa K, Watanabe N, et al
    The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational study.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  34. AN JH, Kim SG
    L-carnitine supplementation in hypothyroidism [Letter to the Editor].
    Endocr J. 2016.
    PubMed     Text format    


  35. BENVENGA S, Sindoni A
    L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment [Letter to the Editor].
    Endocr J. 2016.
    PubMed     Text format    


  36. SHINOHARA S, Kikuchi M, Harada H, Takebayashi S, et al
    The influence of American Society of Anesthesiologists Physical Status on patient morbidity and survival after total thyroidectomy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    July 2016
  37. ITO Y, Hirokawa M, Miyauchi A, Masuoka H, et al
    Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  38. AN JH, Kim YJ, Kim KJ, Kim SH, et al
    L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  39. IDE A, Amino N, Nishihara E, Kudo T, et al
    Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  40. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  41. MATSUZAWA K, Izawa S, Okura T, Fujii S, et al
    Implications of FoxP3-positive and -negative CD4+ CD25+ T cells in Graves' ophthalmopathy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  42. LESMANA R, Iwasaki T, Iizuka Y, Amano I, et al
    The change in thyroid hormone signaling by altered training intensity in male rat skeletal muscle.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  43. UEDA-SAKANE Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, et al
    Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    May 2016
  44. CAI TT, Zhang J, Wang X, Song RH, et al
    Gene-gene and gene-sex epistatic interactions of DNMT1, DNMT3A and DNMT3B in autoimmune thyroid disease.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  45. ITO Y, Suzuki S, Ito KI, Imai T, et al
    Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review].
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    April 2016
  46. KAGAWA T, Watanabe M, Inoue N, Otsu H, et al
    Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto's disease.
    Endocr J. 2016;63:375-80.
    PubMed     Text format     Abstract available


  47. KIHARA M, Miyauchi A, Kudo T, Hirokawa M, et al
    Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  48. ITO Y, Miyauchi A, Kihara M, Kudo T, et al
    Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients' carcinoma death.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  49. CHACHAMOVITZ DS, Vigario PD, Silva SO, Teixeira LB, et al
    Does low-normal serum TSH level adversely impact cognition in elderly adults and might methimazole therapy improve outcomes?
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    March 2016
  50. TRIMBOLI P, Centanni M, Virili C
    Liquid liothyronine to obtain target TSH in differentiated thyroid cancer patients.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  51. LEE YS, Chang HS, Park CS
    Changing trends in the management of well-differentiated thyroid carcinoma in Korea.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  52. MUSSAZHANOVA Z, Akazawa Y, Matsuda K, Shichijo K, et al
    Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  53. SUZUKI S, Yamashita S, Fukushima T, Nakano K, et al
    The protocol and preliminary baseline survey results of the thyroid ultrasound examination in Fukushima.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  54. ONO Y, Fujita M, Ono S, Ogata S, et al
    A rabbit model of fatal hypothyroidism mimicking "myxedema coma" established by microscopic total thyroidectomy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  55. KIM BY, Mok JO, Kang SK, Jang SY, et al
    The relationship between serum adipocytokines and Graves' ophthalmopathy: A hospital-based study.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  56. CAI J, Fang Y, Jing D, Xu S, et al
    Reference intervals of thyroid hormones in a previously iodine-deficient but presently more than adequate area of Western China: a population-based survey.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  57. HIROKAWA M, Sugitani I, Kakudo K, Sakamoto A, et al
    Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    January 2016
  58. TRIMBOLI P, Nigri G, Guidobaldi L, Romanelli F, et al
    Early diagnosis by FNA cytology should not influence the outcome of differentiated thyroid cancer.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  59. KIM GR, Shin JH, Hahn SY, Ko EY, et al
    Ultrasonographic features and clinical characteristics of Warthin-like variant of papillary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  60. MORITANI S
    Impact of superior mediastinal metastasis on the prognosis of papillary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    December 2015
  61. TOMODA C, Ogimi Y, Saito F, Masaki C, et al
    Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  62. HASHIMOTO K, Tagami T, Yamakage H, Muranaka K, et al
    Serum free thyroxine levels is associated with the efficacy of weight reduction therapy in obese female patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  63. YOSHIOKA W, Miyauchi A, Ito M, Kudo T, et al
    Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  64. ITO Y, Oda H, Miyauchi A
    Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    November 2015
  65. UCHIDA T, Suzuki R, Kasai T, Onose H, et al
    Cutoff value of thyroid uptake of Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  66. MUKASA K, Yoshimura Noh J, Kouzaki A, Ohye H, et al
    TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  67. YOSHIE N, Watanabe M, Inoue N, Kawaguchi H, et al
    Association of polymorphisms in the ICOS and ICOSL genes with the pathogenesis of autoimmune thyroid diseases.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  68. KUNII Y, Uruno T, Mukasa K, Sekiya K, et al
    Inhibitory effect of low-dose inorganic iodine on thyroidal radioactive iodine uptake in healthy Japanese adults.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    October 2015
  69. OZKAN C, Akturk M, Altinova AE, Cerit ET, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancer.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  70. KAMMORI M, Fukumori T, Sugishita Y, Hoshi M, et al
    Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  71. HIRATSUKA I, Itoh M, Yamada H, Yamamoto K, et al
    Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  72. ISHIDO Y, Luo Y, Yoshihara A, Hayashi M, et al
    Follicular thyroglobulin enhances gene expression necessary for thyroid hormone secretion.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  73. SUZUKI A, Hirokawa M, Takada N, Higuchi M, et al
    Diagnostic significance of PAX8 in thyroid squamous cell carcinoma.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    July 2015
  74. GE JF, Xu YY, Li N, Zhang Y, et al
    Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  75. YI JW, Park JY, Sung JY, Kwak SH, et al
    Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  76. HANAOKA M, Arata N, Sago H
    Change of maternal thyroid function in twin-twin transfusion syndrome.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  77. TAMADA D, Kitamura T, Onodera T, Hamasaki T, et al
    Clinical significance of fluctuations in thyroid hormones after surgery for Cushing's syndrome.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    June 2015
  78. TAKESHIMA K, Inaba H, Ariyasu H, Furukawa Y, et al
    Clinicopathological features of Riedel's thyroiditis associated with IgG4-related disease in Japan.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    May 2015
  79. TAKESHIMA K, Ariyasu H, Inaba H, Inagaki Y, et al
    Distribution of serum immunoglobulin G4 levels in Hashimoto's thyroiditis and clinical features of Hashimoto's thyroiditis with elevated serum immunoglobulin G4 levels.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  80. KANG S, Amino N, Kudo T, Nishihara E, et al
    Occurrence of thyroxine tablet (Thyradin S) - induced liver dysfunction in a patient with subclinical hypothyroidism.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  81. WU H, Zhang B
    Ultrasonographic appearance of focal Hashimoto's thyroiditis: A single institution experience.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    January 2015
  82. FUKUHARA N, Horiguchi K, Nishioka H, Suzuki H, et al
    Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Endocr J. 2015;62:21-7.
    PubMed     Text format     Abstract available


  83. UEDA Y, Tagami T, Tamanaha T, Kakita M, et al
    A family of RTHbeta with p.R316C mutation presenting occasional syndrome of inappropriate secretion of TSH.
    Endocr J. 2015;62:251-60.
    PubMed     Text format     Abstract available


  84. NARUMI S, Hasegawa T
    TSH resistance revisited.
    Endocr J. 2015;62:393-8.
    PubMed     Text format     Abstract available


  85. SHIRAISHI M, Yamamoto Y, Hirooka N, Obuchi Y, et al
    A high concentration of triiodothyronine attenuates the stimulatory effect on hemin-induced erythroid differentiation of human erythroleukemia K562 cells.
    Endocr J. 2015;62:431-40.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: